Discovering new biomarkers
Using novel techniques with extremely small sample sizes, which are typical to rare diseases and personalised medicines, Volv builds predictive diagnostic algorithms that outperform human clinical diagnostic performance by looking at data earlier in the patient journey and by identifying cognitive biomarkers, digital biomarkers and medical biomarkers that drive a completely new way to diagnose.
These biomarkers are discovered by the model learning process, and we often find them out only as the model improves and as we are subsequently deriving clinically interpretable models.
Contact us to find out more about what these biomarkers might look like for the diseases that you are interested in.
Thank you for submitting your details, we will be in contact with you with the information requested, shortly.